美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
39703 A II 2024/03/20 PORTON PHARMA SOLUTIONS LTD CANAGLIFLOZIN
39507 A II 2024/03/20 DR REDDYS LABORATORIES LTD RELUGOLIX
39594 A II 2024/03/20 STEROID SPA ESTRADIOL VALERATE
39614 A II 2024/03/20 JIANGSU SYNTHGENE BIOTECHNOLOGY CO LTD CYTIDINE TRIPHOSPHATE (CTP) TRIS SOLUTION
39667 A II 2024/03/19 FISHFA BIOGENICS (A DIV OF FISHFA RUBBERS LTD) TACROLIMUS USP
39692 A II 2024/03/19 BREATHGREEN PHARMACEUTICAL CO LTD GLYCOPYRRONIUM BROMIDE (MICRONIZED AND NON-MICRONIZED)
39741 A II 2024/03/19 MURLI KRISHNA PHARMA PVT LTD ESOMEPRAZOLE PELLETS 22.5% W/W
39097 A II 2024/03/19 CHONGQING SINTAHO PHARMACEUTICAL CO LTD TIRBANIBULIN
39569 A II 2024/03/19 LINHAI TIANYU PHARMACEUTICAL CO LTD TICAGRELOR
39613 A II 2024/03/19 JIANGSU SYNTHGENE BIOTECHNOLOGY CO LTD GUANOSINE TRIPHOSPHATE (GTP) TRIS SOLUTION
39264 A II 2024/03/18 HUBEI HONCH PHARMACEUTICAL CO LTD VINBLASTINE SULFATE PHARMACEUTICAL INTERMEDATE
39612 A II 2024/03/18 JIANGSU SYNTHGENE BIOTECHNOLOGY CO LTD N1-METHYL-PSEUDOURIDINE 5'-TRIPHOSPHATE(N1-ME-PUTP) TRIS SOLUTION
39631 A II 2024/03/18 GLOBAL CALCIUM PRIVATE LTD FERRIC CARBOXY MALTOSE
39655 A II 2024/03/17 ZHEJIANG PEPTITES BIOTECH CO LTD TIRZEPATIDE
39313 A II 2024/03/15 ALKEM LABORATORIES LTD NEBIVOLOL HYDROCHLORIDE
39679 A II 2024/03/15 CHANGZHOU PHARMACEUTICAL FACTORY TICAGRELOR INTERMEDIATE (CODE TGA-B-4)
39680 A II 2024/03/15 CHANGZHOU PHARMACEUTICAL FACTORY SACUBITRIL INTERMEDIATE (CODE: SX-6)
39735 A III 2024/03/15 CHANGZHOU HUAJIAN PHARM PACK MATERIAL CO LTD PA/A1/PP OR PE COLD-FORMED FOIL FOR SOLID PREPARATION
38837 A IV 2024/03/15 CATALENT FRANCE BEINHEIM SA GELATIN MASS FOR SOFT GELATIN CAPSULES
39365 A II 2024/03/14 GLOBAL CALCIUM PRIVATE LTD MIDAZOLAM USP

数据库说明:

当前数据更新日期:2024年6月(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2024 DrugFuture->U.S. FDA Drug Master Files